Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David F L Liew

Showing results (11-20 of 35) with videos related to

Pageof 4
Sort By:
Rheumatic Diseases Clinics of North America|April 26, 2024
Immune Checkpoint Inhibitor-induced Polymyalgia RheumaticaDavid F L Liew, Sarah L Mackie, Alice Tison, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|July 20, 2022
Artificial Intelligence and Deep Learning for RheumatologistsChristopher McMaster, Alix Bird, David F L Liew, et al.
Med (New York, N.Y.)|December 9, 2020
The Potential for Repurposing Anti-TNF as a Therapy for the Treatment of COVID-19Philip C Robinson, David F L Liew, Jean W Liew, et al.
BMC Rheumatology|October 16, 2022
Attitudes and practices in the laboratory monitoring of conventional synthetic disease modifying anti-rheumatic drugs by rheumatologists and rheumatology traineesJames J Tsakas, David F L Liew, Cameron L Adams, et al.
Rheumatology Advances in Practice|March 27, 2023
Diagnosis of septic arthritis in the acute care setting: the value of routine intra-operative sample culturePallavi Shamdasani, David F L Liew, Michael Nohrenberg, et al.
Best Practice & Research. Clinical Rheumatology|June 5, 2023
Imaging of giant cell arteritis - recent advancesClaire E Owen, Max Yates, David F L Liew, et al.
Rheumatology and Therapy|August 27, 2021
Systematic Review and Meta-Analysis of Inflammatory Bowel Disease Adverse Events with Anti-Interleukin 17A Agents and Tumor Necrosis Factor Inhibitors in Rheumatic Disease and Skin PsoriasisSteven L Truong, Jasmine Chin, David F L Liew, et al.
Kidney International|November 17, 2024
Post-hoc analysis of the CARES trial suggests delayed progression of chronic kidney disease in patients with gout during urate-lowering therapyByeongzu Ghang, Jino Park, Ji Sung Lee, et al.
Drug Safety|July 16, 2024
A Systematic Overview of Contraindications and Special Warnings for Biologic and Targeted Synthetic Disease Modifying Antirheumatic Drugs: Establishing a Framework to Create a "Safety Checklist"Lykke Skaarup, Elvina Ingrid, Alexandre Sepriano, et al.
Rheumatology (Oxford, England)|July 11, 2025
Changes to physical function and body composition during the first two years of polymyalgia rheumaticaJessica L Leung, Belinda De Ross, Jenny Gianoudis, et al.
Pageof 4

Showing results (11-20 of 35) with videos related to

Sort By:
Pageof 4
Rheumatic Diseases Clinics of North America|April 26, 2024
Immune Checkpoint Inhibitor-induced Polymyalgia RheumaticaDavid F L Liew, Sarah L Mackie, Alice Tison, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|July 20, 2022
Artificial Intelligence and Deep Learning for RheumatologistsChristopher McMaster, Alix Bird, David F L Liew, et al.
Med (New York, N.Y.)|December 9, 2020
The Potential for Repurposing Anti-TNF as a Therapy for the Treatment of COVID-19Philip C Robinson, David F L Liew, Jean W Liew, et al.
BMC Rheumatology|October 16, 2022
Attitudes and practices in the laboratory monitoring of conventional synthetic disease modifying anti-rheumatic drugs by rheumatologists and rheumatology traineesJames J Tsakas, David F L Liew, Cameron L Adams, et al.
Rheumatology Advances in Practice|March 27, 2023
Diagnosis of septic arthritis in the acute care setting: the value of routine intra-operative sample culturePallavi Shamdasani, David F L Liew, Michael Nohrenberg, et al.
Best Practice & Research. Clinical Rheumatology|June 5, 2023
Imaging of giant cell arteritis - recent advancesClaire E Owen, Max Yates, David F L Liew, et al.
Rheumatology and Therapy|August 27, 2021
Systematic Review and Meta-Analysis of Inflammatory Bowel Disease Adverse Events with Anti-Interleukin 17A Agents and Tumor Necrosis Factor Inhibitors in Rheumatic Disease and Skin PsoriasisSteven L Truong, Jasmine Chin, David F L Liew, et al.
Kidney International|November 17, 2024
Post-hoc analysis of the CARES trial suggests delayed progression of chronic kidney disease in patients with gout during urate-lowering therapyByeongzu Ghang, Jino Park, Ji Sung Lee, et al.
Drug Safety|July 16, 2024
A Systematic Overview of Contraindications and Special Warnings for Biologic and Targeted Synthetic Disease Modifying Antirheumatic Drugs: Establishing a Framework to Create a "Safety Checklist"Lykke Skaarup, Elvina Ingrid, Alexandre Sepriano, et al.
Rheumatology (Oxford, England)|July 11, 2025
Changes to physical function and body composition during the first two years of polymyalgia rheumaticaJessica L Leung, Belinda De Ross, Jenny Gianoudis, et al.
Pageof 4